Are Probiotic Really Safe for Humans?

Abe F, Muto M, Yaeshima T, Iwatsuki K, Aihara H, Ohashi Y, Fujisawa T. 2010. Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability. Anaerobe. 16:131–136.AbeFMutoMYaeshimaTIwatsukiKAiharaHOhashiYFujisawaT.2010Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation abilityAnaerobe.1613113610.1016/j.anaerobe.2009.07.006Search in Google Scholar

Agostoni C, Salvini F. 2009. Probiotics in Infant Dietetics. In: Michail S, Sherman PM, editors. Probiotics in Pediatric Medicine. New York (USA): Humana Press.AgostoniCSalviniF.2009Probiotics in Infant Dietetics. In:MichailSShermanPM, editors.Probiotics in Pediatric MedicineNew York (USA)Humana Press10.1007/978-1-60327-289-6_8Search in Google Scholar

Ambesh P, Stroud S, Franzova E, Gotesman J, Sharma K, Wolf L, Kamholz S. 2017. Recurrent Lactobacillus bacteremia in a patient with leukemia. J Investig Med High Impact Case Rep. 5:1–3.AmbeshPStroudSFranzovaEGotesmanJSharmaKWolfLKamholzS.2017Recurrent Lactobacillus bacteremia in a patient with leukemiaJ Investig Med High Impact Case Rep.51310.1177/2324709617744233Search in Google Scholar

Ammor MS, Florez AB, Mayo B. 2007. Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteria. Food Microbiol. 24:559–570.AmmorMSFlorezABMayoB.2007Antibiotic resistance in non-enterococcal lactic acid bacteria and bifidobacteriaFood Microbiol.2455957010.1016/j.fm.2006.11.001Search in Google Scholar

Ashraf A, Shah NP. 2011. Antibiotic resistance of probiotic organisms and safety of probiotic dairy products. Int Food Res J. 18:837–853.AshrafAShahNP.2011Antibiotic resistance of probiotic organisms and safety of probiotic dairy productsInt Food Res J.18837853Search in Google Scholar

Bayer AS, Chow AW, Betts D, Guze LB. 1978. Lactobacillemia: report of 9 cases: important clinical and therapeutic considerations. Am J Med. 64:808–813.BayerASChowAWBettsDGuzeLB.1978Lactobacillemia: report of 9 cases: important clinical and therapeutic considerationsAm J Med.6480881310.1016/0002-9343(78)90521-1Search in Google Scholar

Belletti N, Gatti M, Bottari B, Neviani E, Tabanelli G, Gardinni F. 2009. Antibiotic resistance of lactobacilli isolated from two Italian hard cheeses. J Food Prot. 72:2162–2169.BellettiNGattiMBottariBNevianiETabanelliGGardinniF.2009Antibiotic resistance of lactobacilli isolated from two Italian hard cheesesJ Food Prot.722162216910.4315/0362-028X-72.10.2162Search in Google Scholar

Berg RD. 1985. Bacterial translocation from the intesties. Exp Anim. 34:1–16.BergRD.1985Bacterial translocation from the intestiesExp Anim.3411610.1538/expanim1978.34.1_13987819Search in Google Scholar

Berg RD. 1992. Translocation and the indigenous gut flora. In: Fuller R. Probiotics: The Scientific Basis. London (UK): Chapman & Hall. p. 55–85.BergRD.1992Translocation and the indigenous gut flora. In:FullerR.Probiotics: The Scientific BasisLondon (UK)Chapman & Hall. p.558510.1007/978-94-011-2364-8_4Search in Google Scholar

Bongaerts G, Bakkeren J, Severijnen R, Sperl W, Willems H, Naber T, Wevers R, van Meurs A, Tolboom J. 2000. Lactobacilli and acidosis in children with short small bowel. J Pediatr Gastroenterol Nutr. 30:288–293.BongaertsGBakkerenJSeverijnenRSperlWWillemsHNaberTWeversRvan MeursATolboomJ.2000Lactobacilli and acidosis in children with short small bowelJ Pediatr Gastroenterol Nutr.3028829310.1097/00005176-200003000-0001410749413Search in Google Scholar

Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schhrezenmeir J, Vaara M, Valtonen V. 2003. Safety of probiotics that contain lactobacilli and bifidobacteria. Clin Infect Dis. 36:775–780.BorrielloSPHammesWPHolzapfelWMarteauPSchhrezenmeirJVaaraMValtonenV.2003Safety of probiotics that contain lactobacilli and bifidobacteriaClin Infect Dis.3677578010.1086/36808012627362Search in Google Scholar

Boyle RJ, Robins-Browne RM, Tang ML. 2006. Probiotic use in clinical practice: what are the risks? Am J Clin Nutr. 83:1256–1264.BoyleRJRobins-BrowneRMTangML.2006Probiotic use in clinical practice: what are the risks?Am J Clin Nutr.831256126410.1093/ajcn/83.6.1256Search in Google Scholar

Brook I. 1996. Isolation of non-sporing anaerobic rods from infections in children. J Med Microbiol. 45:21–26.BrookI.1996Isolation of non-sporing anaerobic rods from infections in childrenJ Med Microbiol.45212610.1099/00222615-45-1-21Search in Google Scholar

Brughton RA, Gruber WC, Haffar AA, Baker CJ. 1983. Neonatal meningitis due to Lactobacillus. Pediatr Infect Dis J. 2:382–384.BrughtonRAGruberWCHaffarAABakerCJ.1983Neonatal meningitis due to LactobacillusPediatr Infect Dis J.238238410.1097/00006454-198309000-00012Search in Google Scholar

Brumfitt W, Ludlam H, Hamilton-Miller JMT, Gooding A. 1981. Lactobacilli do not cause frequency and dysuria a syndrome. Lancet. 2:393–395BrumfittWLudlamHHamilton-MillerJMTGoodingA.1981Lactobacilli do not cause frequency and dysuria a syndromeLancet239339510.1016/S0140-6736(81)90833-3Search in Google Scholar

Burkhardt O, Köhnlein T, Pletz M, Welte T. 2005. Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole. Scand J Inf Dis. 37:69–72.BurkhardtOKöhnleinTPletzMWelteT.2005Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazoleScand J Inf Dis.37697210.1080/00365540510026454Search in Google Scholar

Charteris WP, Kelly PM, Morelli L, Collins JK. 1998. Antibiotic susceptibility of potentially probiotic Lactobacillus species. J Food Prot. 61:1636–1643.CharterisWPKellyPMMorelliLCollinsJK.1998Antibiotic susceptibility of potentially probiotic Lactobacillus speciesJ Food Prot.611636164310.4315/0362-028X-61.12.1636Search in Google Scholar

Coeuret V, Gueguen M, Vernoux JP. 2004. Numbers and strains of lactobacilli in some probiotic products. Int J Food Microbiol. 97:147–156.CoeuretVGueguenMVernouxJP.2004Numbers and strains of lactobacilli in some probiotic productsInt J Food Microbiol.9714715610.1016/j.ijfoodmicro.2004.04.015Search in Google Scholar

De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. 2005. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Ped Infect Dis J. 24:278–280.De GrooteMAFrankDNDowellEGlodeMPPaceNR.2005Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndromePed Infect Dis J.2427828010.1097/01.inf.0000154588.79356.e6Search in Google Scholar

Dessart SR, Steenson LR. 1991. High frequency intergeneric and intrageneric conjugal transfer of drug resistance plasmids in Leuconostoc mesenteroides ssp cremoris. J Dairy Sci. 74:2912–2919.DessartSRSteensonLR.1991High frequency intergeneric and intrageneric conjugal transfer of drug resistance plasmids in Leuconostoc mesenteroides ssp cremoris.J Dairy Sci.742912291910.3168/jds.S0022-0302(91)78474-9Search in Google Scholar

Dickgieber U, Weiss N, Fritsche D. 1984. Lactobacillus gasseri as the cause of septic urinary infection. Infection. 12:14–16.DickgieberUWeissNFritscheD.1984Lactobacillus gasseri as the cause of septic urinary infectionInfection.12141610.1007/BF016410176323318Search in Google Scholar

Doron S, Snydman DR. 2015. Risk and safety of probiotics. Clin Infect Dis. 60(Suppl 2):129–134.DoronSSnydmanDR.2015Risk and safety of probioticsClin Infect Dis.60(Suppl 2):12913410.1093/cid/civ085Search in Google Scholar

European Food Safety Authority. 2012. Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J. 10(2740):1–10.European Food Safety Authority.2012Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importanceEFSA J.10(2740):110Search in Google Scholar

Fukao M, Yajima N. 2012. Assessment of antibiotic resistance in probiotic lactobacilli. In: Pana M, editor. Antibiotic resistant bacteria – A continuous challenge in the new millennium. London (UK): IntechOpen [Internet]. doi: 10.5772/30903; [cited 2017 December 20]. Available from: http://www.intechopen.com/books/antibiotic-resistant-bacteria-a-continuous-challenge-in-the-new-millennium/assessment-of-antibiotic-resistance-in-probiotic-strainsFukaoMYajimaN.2012Assessment of antibiotic resistance in probiotic lactobacilli. In:PanaM, editor.Antibiotic resistant bacteria – A continuous challenge in the new millenniumLondon (UK)IntechOpen[Internet]. doi:10.5772/30903; [cited 2017 December 20]. Available from: http://www.intechopen.com/books/antibiotic-resistant-bacteria-a-continuous-challenge-in-the-new-millennium/assessment-of-antibiotic-resistance-in-probiotic-strainsOpen DOISearch in Google Scholar

Gevers D, Danielsen M, Huys G, Swings J. 2003a. Molecular characterization of tet(M) genes in Lactobacillus isolates from different types of fermented dry sausage. Appl Environ Microbiol. 69:1270–1275.GeversDDanielsenMHuysGSwingsJ.2003aMolecular characterization of tet(M) genes in Lactobacillus isolates from different types of fermented dry sausageAppl Environ Microbiol.691270127510.1128/AEM.69.2.1270-1275.2003Search in Google Scholar

Gevers D, Huys G, Swings J. 2003b. In vitro conjugal transfer of tetracycline resistance from Lactobacillus isolates to other Gram-positive bacteria. FEMS Microbiol Lett. 225:125–130.GeversDHuysGSwingsJ.2003bIn vitro conjugal transfer of tetracycline resistance from Lactobacillus isolates to other Gram-positive bacteriaFEMS Microbiol Lett.22512513010.1016/S0378-1097(03)00505-6Search in Google Scholar

Global Market Insights [Internet]. 2017. Los Ageles (USA): Globe-Newswire; [cited 2018 March 14]. Available from: globenewswire.com/news-release/2017/10/10/1143574/0/en/Probiotics-Market-to-exceed-65bn-by-2024-Global-Market-Insights-Inc.htmlGlobal Market Insights [Internet]2017Los Ageles (USA)Globe-Newswire; [cited 2018 March 14]. Available from: globenewswire.com/news-release/2017/10/10/1143574/0/en/Probiotics-Market-to-exceed-65bn-by-2024-Global-Market-Insights-Inc.htmlSearch in Google Scholar

Gueimonde M, Ouwehand AC, Salminen S. 2004. Safety of probiotics. Scand J Nutr. 48:42–48.GueimondeMOuwehandACSalminenS.2004Safety of probioticsScand J Nutr.48424810.1080/11026480410026447Search in Google Scholar

Guo H, Pan L, Li L, Lu J, Kwok L, Menghe B, Zhang H, Zhang W. 2017. Characterization of antibiotic resistance genes from lactobacillus isolated from traditional dairy products. J Food Sci. 82:724–730.GuoHPanLLiLLuJKwokLMengheBZhangHZhangW.2017Characterization of antibiotic resistance genes from lactobacillus isolated from traditional dairy productsJ Food Sci.8272473010.1111/1750-3841.13645Search in Google Scholar

Harty DWS, Oakey HJ, Patrikakis M, Hume EBH, Knox KW. 1994. Pathogenic potential of lactobacilli. Int J Food Microbiol. 24:179–189.HartyDWSOakeyHJPatrikakisMHumeEBHKnoxKW.1994Pathogenic potential of lactobacilliInt J Food Microbiol.2417918910.1016/0168-1605(94)90117-1Search in Google Scholar

Harty DWS, Patrikakis M, Knox KW. 1993. Identification of Lactobacillus strains from patients with infective endocarditis and comparison of their surface-associated properties with those of other strains of the same species. Microb Ecol Health Dis. 6:191–201.HartyDWSPatrikakisMKnoxKW.1993Identification of Lactobacillus strains from patients with infective endocarditis and comparison of their surface-associated properties with those of other strains of the same speciesMicrob Ecol Health Dis.619120110.3109/08910609309141327Search in Google Scholar

Hempel S, Newberry S, Ruelaz A, Wang Z, Miles JN, Suttorp MJ, Johansen B, Shanman R, Slusser W, Fu N, et al. 2011. Safety of probiotics used to reduce risk and prevent or treat disease. Evid Rep Technol Assess. 200:1–645.HempelSNewberrySRuelazAWangZMilesJNSuttorpMJJohansenBShanmanRSlusserWFuN2011Safety of probiotics used to reduce risk and prevent or treat disease.Evid Rep Technol Assess.2001645Search in Google Scholar

Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S. 2014. Expert consensus document ”The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic”. Nat Rev Gastroenterol Hepatol. 11:506–514.HillCGuarnerFReidGGibsonGRMerensteinDJPotBMorelliLCananiRBFlintHJSalminenS.2014Expert consensus document ”The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic”Nat Rev Gastroenterol Hepatol.1150651410.1038/nrgastro.2014.6624912386Search in Google Scholar

Hoa NT, Baccigalupi L, Huxham A, Smertenko A, Van PH, Ammendola S, Ricca E, Cutting AS. 2000. Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disorders. Appl Environ Microbiol. 66: 5241–5247.HoaNTBaccigalupiLHuxhamASmertenkoAVanPHAmmendolaSRiccaECuttingAS.2000Characterization of Bacillus species used for oral bacteriotherapy and bacterioprophylaxis of gastrointestinal disordersAppl Environ Microbiol.665241524710.1128/AEM.66.12.5241-5247.20009245111097897Search in Google Scholar

Horwitch CA, Furseth HA, Larson AM, Jones TL, Olliffe JF, Spach DH. 1995. Lactobacillemia in three patients with AIDS. Clin Infect Dis. 21:1460–1462.HorwitchCAFursethHALarsonAMJonesTLOlliffeJFSpachDH.1995Lactobacillemia in three patients with AIDSClin Infect Dis.211460146210.1093/clinids/21.6.1460Search in Google Scholar

Hove H, Mortensen PB. 1995. Influence of intestinal inflammation (IBD) and small and large-bowel length on fecal short-chain fattyacids and lactate. Dig Dis Sci. 40:1372–1380.HoveHMortensenPB.1995Influence of intestinal inflammation (IBD) and small and large-bowel length on fecal short-chain fattyacids and lactateDig Dis Sci.401372138010.1007/BF02065554Search in Google Scholar

Ishibashi N, Yamazaki S. 2001. Probiotics and safety. Am J Clin Nutr. 73(Suppl):465S–470S.IshibashiNYamazakiS.2001Probiotics and safetyAm J Clin Nutr.73(Suppl):465S470S10.1093/ajcn/73.2.465sSearch in Google Scholar

Johnson BR, Klaenhammer TR. 2014. Impact of genomics on the field of probiotic research: historical perspectives to modern paradigms. Antoine van Leeuwenhoek. 106:141–156.JohnsonBRKlaenhammerTR.2014Impact of genomics on the field of probiotic research: historical perspectives to modern paradigmsAntoine van Leeuwenhoek.10614115610.1007/s10482-014-0171-ySearch in Google Scholar

Kalima P, Masterton RG, Roddie PH, Thomas AE. 1996. Lactobacillus rhamnosus infection in a child following bone marrow transplant. J Infect. 32:165–167.KalimaPMastertonRGRoddiePHThomasAE.1996Lactobacillus rhamnosus infection in a child following bone marrow transplantJ Infect.3216516710.1016/S0163-4453(96)91622-9Search in Google Scholar

Kochan P, Chmielarczyk A, Szymaniak L, Brykczynski M, Galant K, Zych A, Pakosz K, Giedrys-Kalemba S, Lenouvel E, Heczko PB. 2011. Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient – is the time right to revise probiotic safety guidelines? Clin Microbiol Infect. 17:1589–1592.KochanPChmielarczykASzymaniakLBrykczynskiMGalantKZychAPakoszKGiedrys-KalembaSLenouvelEHeczkoPB.2011Lactobacillus rhamnosus administration causes sepsis in a cardiosurgical patient – is the time right to revise probiotic safety guidelines?Clin Microbiol Infect.171589159210.1111/j.1469-0691.2011.03614.x21848974Search in Google Scholar

Kunz AN, Noel JM, Fairchok MP. 2004. Two cases of Lactobacillus bacteremia during probiotc treatment of short gut syndrome. J Ped Gastroent Nutr. 38:457–458.KunzANNoelJMFairchokMP.2004Two cases of Lactobacillus bacteremia during probiotc treatment of short gut syndromeJ Ped Gastroent Nutr.3845745810.1097/00005176-200404000-0001715085028Search in Google Scholar

Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. 2005. Lactobacillus sepsis associated with probiotic therapy. Pediatrics. 115:178–181.LandMHRouster-StevensKWoodsCRCannonMLCnotaJShettyAK.2005Lactobacillus sepsis associated with probiotic therapyPediatrics.11517818110.1542/peds.2004-213715629999Search in Google Scholar

Ledoux D, Labombardi VJ, Karter D. 2006. Lactobacillus acidophilus bacteremia after use of a probiotic in a patient with AIDS and Hodgkin’s disease. Int J STD AIDS. 17:280–282.LedouxDLabombardiVJKarterD.2006Lactobacillus acidophilus bacteremia after use of a probiotic in a patient with AIDS and Hodgkin’s diseaseInt J STD AIDS.1728028210.1258/09564620677625350716595054Search in Google Scholar

Lee TT, Morisset M, Astier C, Moneret-Vautrin DA, Cordebar V, Beaudouin E, Codreanu F, Bihain BE, Kanny G. 2007. Contamination of probiotic preparations with milk allergens can cause anaphylaxis in children with cow’s milk allergy. J Allergy Clin Immunol. 119:746–747.LeeTTMorissetMAstierCMoneret-VautrinDACordebarVBeaudouinECodreanuFBihainBEKannyG.2007Contamination of probiotic preparations with milk allergens can cause anaphylaxis in children with cow’s milk allergyJ Allergy Clin Immunol.11974674710.1016/j.jaci.2006.11.01117270264Search in Google Scholar

Lilly DM, Stillwell RH. 1965. Growth promoting factors produced by probiotics. Science. 147:747–748.LillyDMStillwellRH.1965Growth promoting factors produced by probioticsScience.14774774810.1126/science.147.3659.747Search in Google Scholar

Liong MT. 2008. Safety of probiotics: translocation and infection. Nutr Rev. 66:192–202.LiongMT.2008Safety of probiotics: translocation and infectionNutr Rev.6619220210.1111/j.1753-4887.2008.00024.xSearch in Google Scholar

Liu Ch, Zhang Z, Dong K, Yuan J, Guo X. 2009. Antibiotic resistance of probiotic strains of lactic acid bacteria isolated from marketed foods and drugs. Biomed Env Sci. 22:401–412.LiuChZhangZDongKYuanJGuoX.2009Antibiotic resistance of probiotic strains of lactic acid bacteria isolated from marketed foods and drugsBiomed Env Sci.2240141210.1016/S0895-3988(10)60018-9Search in Google Scholar

Łukasik J, Salminen S, Szajewska H. 2018. Rapid review shows that probiotics and fermented infant formulas do not cause D-lactic acidosis in healthy children. Acta Paediatr. 107:1322–1326.ŁukasikJSalminenSSzajewskaH.2018Rapid review shows that probiotics and fermented infant formulas do not cause D-lactic acidosis in healthy childrenActa Paediatr.1071322132610.1111/apa.1433829603358Search in Google Scholar

Masco L, Huys G, De Brandt E, Temmerman R, Swings J. 2005. Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteria. Int J Food Microbiol. 102:221–230.MascoLHuysGDe BrandtETemmermanRSwingsJ.2005Culture-dependent and culture-independent qualitative analysis of probiotic products claimed to contain bifidobacteriaInt J Food Microbiol.10222123010.1016/j.ijfoodmicro.2004.11.01815992621Search in Google Scholar

Mathur S, Singh R. 2005. Antibiotic resistance in food lactic acid bacteria – a review. Int J Food Microbiol. 105:281–295.MathurSSinghR.2005Antibiotic resistance in food lactic acid bacteria – a reviewInt J Food Microbiol.10528129510.1016/j.ijfoodmicro.2005.03.00816289406Search in Google Scholar

McFarland LV. 2015. From yaks to yogurt: the history, development, and current use of probiotics. Clin Infect Dis. 60(S2):S85–S90.McFarlandLV.2015From yaks to yogurt: the history, development, and current use of probioticsClin Infect Dis.60(S2):S85S9010.1093/cid/civ05425922406Search in Google Scholar

Metchnikoff E. 1908. The prolongation of life. Optimistic studies. New York (USA): Putnam’s Sons. p. 161–183.MetchnikoffE.1908The prolongation of life. Optimistic studiesNew York (USA)Putnam’s Sons. p.161183Search in Google Scholar

Milazzo I, Speciale A, Musumeci R, Fazio D, Blandino G. 2006. Identification and antibiotic susceptibility of bacterial isolates from probiotic products available in Italy. New Microbiol. 29: 281–291.MilazzoISpecialeAMusumeciRFazioDBlandinoG.2006Identification and antibiotic susceptibility of bacterial isolates from probiotic products available in ItalyNew Microbiol.29281291Search in Google Scholar

Moneret-Vautrin DA, Morisset M, Cordebar V, Codreanu F, Kanny G. 2006. Probiotics may be unsafe in infants allergic to cow’s milk. Allergy. 61:507–508.Moneret-VautrinDAMorissetMCordebarVCodreanuFKannyG.2006Probiotics may be unsafe in infants allergic to cow’s milkAllergy.6150750810.1111/j.1398-9995.2006.01050.x16512815Search in Google Scholar

Morelli L, Sarra PG, Bottazzi V. 1988. In vivo transfer of pAM beta 1 from Lactobacillus reuteri to Enterococcus faecalis. J Appl Bacteriol. 65:371–375.MorelliLSarraPGBottazziV.1988In vivo transfer of pAM beta 1 from Lactobacillus reuteri to Enterococcus faecalisJ Appl Bacteriol.6537137510.1111/j.1365-2672.1988.tb01905.x2976754Search in Google Scholar

Moubareck C, Gavini F, Vaugien L, Butel MJ, Doucet-Populaire F. 2005. Antimicrobial susceptibility of Bifidobacteria. J Antimicrob Chemother. 55:38–44.MoubareckCGaviniFVaugienLButelMJDoucet-PopulaireF.2005Antimicrobial susceptibility of BifidobacteriaJ Antimicrob Chemother.55384410.1093/jac/dkh49515574479Search in Google Scholar

Nawaz M, Wang J, Zhou A, Ma C, Wu X, Moore JE, Millar BC, Xu J. 2011. Characterization and transfer of antibiotic resistance in lactic acid bacteria from fermented food products. Curr Microbiol. 62:1081–1089.NawazMWangJZhouAMaCWuXMooreJEMillarBCXuJ.2011Characterization and transfer of antibiotic resistance in lactic acid bacteria from fermented food productsCurr Microbiol.621081108910.1007/s00284-010-9856-2Search in Google Scholar

Ooi LG, Liong MT. 2010. Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings. Int J Mol Sci. 11:2499–2522.OoiLGLiongMT.2010Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findingsInt J Mol Sci.112499252210.3390/ijms11062499Search in Google Scholar

Ouwehand AC, Saxelin M, Salminen S. 2004. Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin Infect Dis. 39: 1858–1860.OuwehandACSaxelinMSalminenS.2004Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from bloodClin Infect Dis.391858186010.1086/425741Search in Google Scholar

Patel R, Cockerill FR, Porayko MK, Osmon DR, Ilstrump DM, Keating MR. 1994. Lactobacillemia in liver transplant patients. Clin Infect. 18:207–212.PatelRCockerillFRPoraykoMKOsmonDRIlstrumpDMKeatingMR.1994Lactobacillemia in liver transplant patientsClin Infect.1820721210.1093/clinids/18.2.207Search in Google Scholar

Report FAO/WHO. 2001. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria [Internet]. p. 1–29; [cited 2017 November 15]. Available from: http://www.fao.org/tempref/docrep/fao/meeting/009/y6398e.pdfReport FAO/WHO.2001Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria [Internet]. p.129;[cited 2017 November 15]. Available from: http://www.fao.org/tempref/docrep/fao/meeting/009/y6398e.pdfSearch in Google Scholar

Report FAO/WHO. 2002. Report of a Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food [Internet]. p. 36–48; [cited 2017 November 15]. Available from: http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdfReport FAO/WHO.2002Report of a Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food [Internet]. p.3648; [cited 2017 November 15]. Available from: http://www.who.int/foodsafety/fs_management/en/probiotic_guidelines.pdfSearch in Google Scholar

Ruseler-van Embden JGH, van Lieshout LMC, Gosselink MJ, Marteau P. 1995. Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins: clearing the way for mucosa-protective therapy. Scand J Gastroenterol. 30:675–680.Ruseler-van EmbdenJGHvan LieshoutLMCGosselinkMJMarteauP.1995Inability of Lactobacillus casei strain GG, L. acidophilus, and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins: clearing the way for mucosa-protective therapyScand J Gastroenterol.3067568010.3109/00365529509096312Search in Google Scholar

Saarela M, Mogensen G, Fonden R, Matto J, Mattila-Sandholm T. 2000. Probiotic bacteria: safety, functional and technological properties. J Biotechnol. 84:197–215.SaarelaMMogensenGFondenRMattoJMattila-SandholmT.2000Probiotic bacteria: safety, functional and technological propertiesJ Biotechnol.8419721510.1016/S0168-1656(00)00375-8Search in Google Scholar

Salminen MK, Rautelin H, Tynkkynen S, Poussa T, Saxelin M, Valtonen V, Järvinen A. 2004. Lactobacillus bacteremia, clinical signifiance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis. 38:62–69.SalminenMKRautelinHTynkkynenSPoussaTSaxelinMValtonenVJärvinenA.2004Lactobacillus bacteremia, clinical signifiance, and patient outcome, with special focus on probiotic L. rhamnosus GGClin Infect Dis.38626910.1086/38045514679449Search in Google Scholar

Salminen MK, Tynkkynen S, Rautelin H, Saxelin M, Vaara M, Ruutu P, Sarna S, Valtonen V, Järvinen A. 2002. Lactobacillus bacteremia during a rapid increase in probiotic use f Lactobacillus rhamnosus GG in Finland. Clin Infect Dis. 35:1155–1160.SalminenMKTynkkynenSRautelinHSaxelinMVaaraMRuutuPSarnaSValtonenVJärvinenA.2002Lactobacillus bacteremia during a rapid increase in probiotic use f Lactobacillus rhamnosus GG in FinlandClin Infect Dis.351155116010.1086/34291212410474Search in Google Scholar

Salyers AA, Gupta A, Wang Y. 2004. Human intestinal bacteria as reservoirs for antibiotic resistance genes. Trends Microbiol. 12:412–416.SalyersAAGuptaAWangY.2004Human intestinal bacteria as reservoirs for antibiotic resistance genesTrends Microbiol.1241241610.1016/j.tim.2004.07.00415337162Search in Google Scholar

Sanders ME, Akkermans LMA, Haller D, Hammerman C, Heimbach J, Hormannsperger G, Huys G, Levy DD, Lutgendorff F, Mack D, et al. 2010. Safety assessment of probiotic for human use. Gut Microbes. 1:164–185.SandersMEAkkermansLMAHallerDHammermanCHeimbachJHormannspergerGHuysGLevyDDLutgendorffFMackD2010Safety assessment of probiotic for human useGut Microbes.116418510.4161/gmic.1.3.12127302359721327023Search in Google Scholar

Sanders ME, Klaenhammer TR, Ouwehand AC, Pot B, Johanses E, Heimbach JT, Marco ML, Tenilä J, Ross RP, Franz C, et al. 2014. Effects of genetic, processing, or product formulation changes on efficacy and safety of probiotics. Ann N.Y. Acad Sci. 1309:1–18.SandersMEKlaenhammerTROuwehandACPotBJohansesEHeimbachJTMarcoMLTeniläJRossRPFranzC2014Effects of genetic, processing, or product formulation changes on efficacy and safety of probioticsAnn N.Y. Acad Sci.130911810.1111/nyas.1236324571253Search in Google Scholar

Schjørring S, Krogfelt KA. 2011. Assessment of bacterial antibiotic resistance transfer in the gut. Int J Microbiol [Internet]:1–10; [cited 2017 December 17]. Available from: http://dx.doi.org/10.1155/2011/312956SchjørringSKrogfeltKA.2011Assessment of bacterial antibiotic resistance transfer in the gutInt J Microbiol [Internet]110; [cited 2017 December 17]. Available from: http://dx.doi.org/10.1155/2011/312956Search in Google Scholar

Schlegel L, Lemerle S, Geslin P. 1998. Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect. 17:887–888.SchlegelLLemerleSGeslinP.1998Lactobacillus species as opportunistic pathogens in immunocompromised patientsEur J Clin Microbiol Infect.1788788810.1007/s10096005021610052559Search in Google Scholar

Senok AC, Ismaeel AY, Botta GA. 2005. Probiotics: facts and myths. Clin Microbiol Infect. 11:958–966.SenokACIsmaeelAYBottaGA.2005Probiotics: facts and mythsClin Microbiol Infect.1195896610.1111/j.1469-0691.2005.01228.x16307549Search in Google Scholar

Shao Y, Zhang W, Guo H, Pan L, Zhang H, Sun T. 2015. Comparative studies on antibiotic resistance in Lactobacillus casei and Lactobacillus plantarum. Food Control. 50:250–258.ShaoYZhangWGuoHPanLZhangHSunT.2015Comparative studies on antibiotic resistance in Lactobacillus casei and Lactobacillus plantarumFood Control.5025025810.1016/j.foodcont.2014.09.003Search in Google Scholar

Sharpe ME, Hill LR, Lapage SP. 1973. Pathogenic lactobacilli. J Med Microbiol. 6:281–286.SharpeMEHillLRLapageSP.1973Pathogenic lactobacilliJ Med Microbiol.628128610.1099/00222615-6-3-2814199269Search in Google Scholar

Sherid M, Samo S, Sulaiman S, Husein H, Sifuentes H, Sridhar S. 2016. Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literature. BMC Gastroenterol. 16:138.SheridMSamoSSulaimanSHuseinHSifuentesHSridharS.2016Liver abscess and bacteremia caused by lactobacillus: role of probiotics? Case report and review of the literatureBMC Gastroenterol.1613810.1186/s12876-016-0552-y511613327863462Search in Google Scholar

Sherman ME, Albrecht M, DeGirolami PC, Kirkley SA, Wolf B, Eliopoulos GM, Rohrer RJ, Monaco AP. 1987. An unusual case of splenic abscess and sepsis in an immunocompromised host. Am J Clin Pathol. 88:659–662.ShermanMEAlbrechtMDeGirolamiPCKirkleySAWolfBEliopoulosGMRohrerRJMonacoAP.1987An unusual case of splenic abscess and sepsis in an immunocompromised hostAm J Clin Pathol.8865966210.1093/ajcp/88.5.6593314473Search in Google Scholar

Snydman DR. 2008. The safety of probiotics. Clin Infect Dis. 46:S104–111.SnydmanDR.2008The safety of probioticsClin Infect Dis.46S10411110.1086/52333118181712Search in Google Scholar

Sriskandan S, Lacey S, Fisher L. 1993. Isolation of vancomycin-resistant lactobacilli from three neutropenic patients with pneumonia. Eur J Clin Microbiol Infect Dis. 12:649–650.SriskandanSLaceySFisherL.1993Isolation of vancomycin-resistant lactobacilli from three neutropenic patients with pneumoniaEur J Clin Microbiol Infect Dis.1264965010.1007/BF019736538223672Search in Google Scholar

Sybesma W, Molenar D, van Ijcken W, Venema K, Kort R. 2013. Genome instability in Lactobacillus rhamnosus GG. Appl Environ Microbiol. 79:2233–2239.SybesmaWMolenarDvan IjckenWVenemaKKortR.2013Genome instability in Lactobacillus rhamnosus GGAppl Environ Microbiol.792233223910.1128/AEM.03566-12362324623354703Search in Google Scholar

Tan KP, Yang M, Ito S. 2007. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress. Mol Pharmacol. 72:1380–1390.TanKPYangMItoS.2007Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stressMol Pharmacol.721380139010.1124/mol.107.039370Search in Google Scholar

Tan LT-H, Chan K-G, Lee L-H, Goh B-H. 2016. Streptomyces bacteria as potential probiotics in aquaculture. Front Microbiol. 7:79.TanLT-HChanK-GLeeL-HGohB-H.2016Streptomyces bacteria as potential probiotics in aquacultureFront Microbiol.77910.3389/fmicb.2016.00079Search in Google Scholar

Temmerman R, Pot B, Huys G, Swings J. 2002. Identification and antibiotic susceptibility of bacterial isolates from probiotic products. Int J Food Microbiol. 81:1–10.TemmermanRPotBHuysGSwingsJ.2002Identification and antibiotic susceptibility of bacterial isolates from probiotic productsInt J Food Microbiol.8111010.1016/S0168-1605(02)00162-9Search in Google Scholar

Teuber M, Meile L, Schwarz F. 1999. Acquired antibiotic resistance in lactic acid bacteria from food. Antoine Van Leeuwenhoek. 76:115–137.TeuberMMeileLSchwarzF.1999Acquired antibiotic resistance in lactic acid bacteria from foodAntoine Van Leeuwenhoek.7611513710.1023/A:1002035622988Search in Google Scholar

Thompson C, McCarter YS, Krause PJ, Herson VC. 2001. Lactobacillus acidophilus sepsis in a neonate. J Perinatol. 21:258–260.ThompsonCMcCarterYSKrausePJHersonVC.2001Lactobacillus acidophilus sepsis in a neonateJ Perinatol.2125826010.1038/sj.jp.7200509Search in Google Scholar

Tissier H. 1906. Treatment of intestinal infections using bacterial flora of the intestine. Crit Rev Soc Biol. 60:359–361.TissierH.1906Treatment of intestinal infections using bacterial flora of the intestineCrit Rev Soc Biol.60359361Search in Google Scholar

Tsai Y-T, Cheng P-C, Pan T-M. 2012. The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits. Appl Microbiol Biotechnol. 96:853–862.TsaiY-TChengP-CPanT-M.2012The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefitsAppl Microbiol Biotechnol.9685386210.1007/s00253-012-4407-3Search in Google Scholar

Tynkkynen S, Singh KV, Varmanen P. 1998. Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genes. Int J Food Microbiol. 41:195–204.TynkkynenSSinghKVVarmanenP.1998Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance (van) genesInt J Food Microbiol.4119520410.1016/S0168-1605(98)00051-8Search in Google Scholar

Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA. 2013. Lactobacillus bacteremia associated with pobiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 47: 437–439.VahabnezhadEMochonABWozniakLJZiringDA.2013Lactobacillus bacteremia associated with pobiotic use in a pediatric patient with ulcerative colitisJ Clin Gastroenterol.4743743910.1097/MCG.0b013e318279abf023426446Search in Google Scholar

Van den Nieuwboer M, Brummer RJ, Guarner F, Cabana M, Morelli L, Claassen E. 2015. Safety of probiotics and synbiotics in children under 18 years of age. Benef Microbes. 6:615–630.Van den NieuwboerMBrummerRJGuarnerFCabanaMMorelliLClaassenE.2015Safety of probiotics and synbiotics in children under 18 years of ageBenef Microbes.661563010.3920/BM2014.015725809217Search in Google Scholar

Van den Nieuwboer M, Claassen E, Morelli L, Guarner F, Brummer RJ. 2014. Probiotic and synbiotic safety in infants under two years of age. Benef Microbes. 5:45–60.Van den NieuwboerMClaassenEMorelliLGuarnerFBrummerRJ.2014Probiotic and synbiotic safety in infants under two years of ageBenef Microbes.5456010.3920/BM2013.004624463207Search in Google Scholar

Van Leeuwen PAM, Boermeester MA, Houdijk APJ, Ferwerda ChC, Cuesta MA, Meyer S. 1994. Clinical significance of translocation. Gut. 35(Suppl):S28–S34.Van LeeuwenPAMBoermeesterMAHoudijkAPJFerwerdaChCCuestaMAMeyerS.1994Clinical significance of translocationGut.35(Suppl):S28S3410.1136/gut.35.1_Suppl.S2813781438125386Search in Google Scholar

Vankerckhoven V, Huys G, Vancanneyt M, Vael C, Klare I, Romond MB, Enteza JM, Moreillon P, Wind RD, Knol J, et al. 2008. Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project. Trend Food Sci Tech. 19:102–114.VankerckhovenVHuysGVancanneytMVaelCKlareIRomondMBEntezaJMMoreillonPWindRDKnolJ2008Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE projectTrend Food Sci Tech.1910211410.1016/j.tifs.2007.07.013Search in Google Scholar

Venugopalan V, Shriner KA, Wong-Beringer A. 2010. Regulatory oversight and safety of probiotic use. Emerging Infect Dis. 11:1661–1665.VenugopalanVShrinerKAWong-BeringerA.2010Regulatory oversight and safety of probiotic useEmerging Infect Dis.111661166510.3201/eid1611.100574329452221029521Search in Google Scholar

Vitetta L, Coulson S, Thomsen M, Nguyen T, Hall S. 2017. Probiotics, D-lactic acidosis, oxidative stress and strain specificity. Gut Microb. 8:311–322.VitettaLCoulsonSThomsenMNguyenTHallS.2017Probiotics, D-lactic acidosis, oxidative stress and strain specificityGut Microb.831132210.1080/19490976.2017.1279379557041828080206Search in Google Scholar

Zawistowska-Rojek A, Zaręba T, Mrówka A, Tyski S. 2016. Assessment of the microbiological status of probiotic products. Pol J Microb. 65:97–104.Zawistowska-RojekAZarębaTMrówkaATyskiS.2016Assessment of the microbiological status of probiotic productsPol J Microb.659710410.5604/17331331.119728127282000Search in Google Scholar

Zheng M, Zhang R, Tian X, Zhou X, Pan X, Wong A. 2017. Assessing the risk of probiotic dietary supplements in the context of antibiotic resistance. Front Microbiol. 8:908.ZhengMZhangRTianXZhouXPanXWongA.2017Assessing the risk of probiotic dietary supplements in the context of antibiotic resistanceFront Microbiol.890810.3389/fmicb.2017.00908543716128579981Search in Google Scholar